Geoff Birkett
2021
In 2021, Geoff Birkett earned a total compensation of $135K as Chief Commercial Officer at Ensysce Biosciences, a 88% increase compared to previous year.
Compensation breakdown
| Salary | $135,000 |
|---|---|
| Total | $135,000 |
Birkett received $135K in salary, accounting for 100% of the total pay in 2021.
Rankings
In 2021, Geoff Birkett's compensation ranked 12,176th out of 12,415 executives tracked by ExecPay. In other words, Birkett earned more than 1.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,176 out of 12,415 | 2nd |
Division Manufacturing | 5,397 out of 5,508 | 2nd |
Major group Chemicals And Allied Products | 2,342 out of 2,378 | 2nd |
Industry group Drugs | 2,067 out of 2,099 | 2nd |
Industry Pharmaceutical Preparations | 1,527 out of 1,549 | 1st |
Source: SEC filing on May 2, 2022.
Birkett's colleagues
We found two more compensation records of executives who worked with Geoff Birkett at Ensysce Biosciences in 2021.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021